Danny has over 25 years of commercial experience in Australian and global pharmaceuticals and medical devices. He has held executive positions in both private and ASX listed entities including Admedus Ltd, Roche and Actelion with a track record of successfully commercialising new medical technologies in Europe, North America, Asia Pacific and MENA.
Geoffrey is a senior executive and medical researcher with over 20 years’ experience in the biopharmaceutical and medical industries. He’s been an expert scientific advisor for numerous global pharmaceutical companies including Pfizer, Novartis, Bayer Pharmaceuticals Australia, Glaxo Smith & Kline (GSK) Australia and Edwards LifeSciences.
Lee holds over 25 years’ experience in the healthcare and technology sectors and has been in executive leadership roles in both Public and Private enterprises. He previously worked in Fortescue Metals Group and led a healthcare technology spin out (Allied Medical) as its CEO and Managing Director that resulted in increasing its valuation from $800k to a peak of $250m (ASX:AHZ, AVR). He was also the Senior Executive of Sirius Minerals Plc that led to its lead acquisition project and reached a peak market capitalisation of over $1 billion on the London exchange. Lee holds an MBA from the University of St Thomas, Minnesota and B.A. degree in Business Management from St John’s University.